DK0381628T3 - Glycocyamidinderivater - Google Patents

Glycocyamidinderivater

Info

Publication number
DK0381628T3
DK0381628T3 DK90810073.8T DK90810073T DK0381628T3 DK 0381628 T3 DK0381628 T3 DK 0381628T3 DK 90810073 T DK90810073 T DK 90810073T DK 0381628 T3 DK0381628 T3 DK 0381628T3
Authority
DK
Denmark
Prior art keywords
glycocyamidine
alkyl group
hydrogen
chem
diagnosis
Prior art date
Application number
DK90810073.8T
Other languages
English (en)
Inventor
Ko Nakamura
Kazuhara Ienaga
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of DK0381628T3 publication Critical patent/DK0381628T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90810073.8T 1989-02-01 1990-01-31 Glycocyamidinderivater DK0381628T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2466989 1989-02-01

Publications (1)

Publication Number Publication Date
DK0381628T3 true DK0381628T3 (da) 1995-05-01

Family

ID=12144550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810073.8T DK0381628T3 (da) 1989-02-01 1990-01-31 Glycocyamidinderivater

Country Status (7)

Country Link
US (1) US4957936A (da)
EP (1) EP0381628B1 (da)
JP (1) JP2957217B2 (da)
AT (1) ATE115951T1 (da)
DE (1) DE69015220T2 (da)
DK (1) DK0381628T3 (da)
ES (1) ES2066181T3 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221689B (da) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
EP1686990B1 (en) * 2003-11-21 2012-09-19 U.S. Army Medical Research and Materiel Command 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
EP2565646B1 (en) 2010-04-27 2017-10-18 Sysmex Corporation Diagnostic marker for kidney diseases and use thereof
EP3416645A4 (en) * 2016-02-18 2019-10-16 Merck Sharp & Dohme Corp. COMPOUNDS FOR THE TREATMENT OF MALARIA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE251937C (da) *
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives

Also Published As

Publication number Publication date
US4957936A (en) 1990-09-18
JPH02288867A (ja) 1990-11-28
EP0381628B1 (en) 1994-12-21
ATE115951T1 (de) 1995-01-15
EP0381628A2 (en) 1990-08-08
JP2957217B2 (ja) 1999-10-04
EP0381628A3 (en) 1991-05-02
DE69015220D1 (de) 1995-02-02
DE69015220T2 (de) 1995-05-11
ES2066181T3 (es) 1995-03-01

Similar Documents

Publication Publication Date Title
AU515774B2 (en) Benzopyran derivatives
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
DE69004164D1 (de) Diphenylharnstoffderivate.
DE3483861D1 (de) Oliglucosidderivate.
FI914187A (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
FI913067A0 (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
ES2188481T3 (es) Derivados de polinalbufina.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES2065994T3 (es) Beta-dicetonas substituidas.
DE69015220D1 (de) Glycocyamidin-Derivate.
FI854596A (fi) Nytt foerfarande foer uppdelning av racemiska -naftylpropionsyror i optiska isomerer.
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
KR960700245A (ko) 메토트렉세이트 유도체[methotrexate derivative]
KR900018083A (ko) 에폭시숙신산 유도체
PT971899E (pt) Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica.
DE69805267D1 (de) Cyclopropancyclus enthaltende Purinderivate
KR910000715A (ko) 3-데옥시 마이카미노실틸로놀리드 유도체
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
DK0455899T3 (da) Prostaglandin I-analog
ES2139670T3 (es) Derivados de 1-fenilpirrolidona con actividad optica y preparacion de los mismos.
KR840001554A (ko) 벤즈아미드 유도체의 제법
TH13791EX (th) อนุพันธ์ต่างๆของกรดบิวไทริค